お知らせ • Feb 04
Golden Sun Health Technology Group Limited announced delayed 20-F filing On 02/03/2026, Golden Sun Health Technology Group Limited announced that they will be unable to file their next 20-F by the deadline required by the SEC. お知らせ • Aug 18
Golden Sun Health Technology Group Limited, Annual General Meeting, Sep 25, 2025 Golden Sun Health Technology Group Limited, Annual General Meeting, Sep 25, 2025, at 10:00 China Standard Time. Location: room 503, building c2, no. 1599 xinjinqiao road, pudong new area, shanghai, China Reported Earnings • Aug 12
First half 2025 earnings released: US$2.94 loss per share (vs US$0.54 loss in 1H 2024) First half 2025 results: US$2.94 loss per share (further deteriorated from US$0.54 loss in 1H 2024). Revenue: US$16.6m (up US$15.2m from 1H 2024). Net loss: US$5.83m (loss widened 448% from 1H 2024). New Risk • Jul 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 64% per year over the past 5 years. Market cap is less than US$10m (US$5.11m market cap). Minor Risk Share price has been volatile over the past 3 months (13% average weekly change). お知らせ • Feb 01
Golden Sun Health Technology Group Limited announced delayed 20-F filing On 01/31/2025, Golden Sun Health Technology Group Limited announced that they will be unable to file their next 20-F by the deadline required by the SEC. New Risk • Oct 06
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: US$8.70m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$9.1m free cash flow). Share price has been highly volatile over the past 3 months (23% average weekly change). Earnings have declined by 77% per year over the past 5 years. Market cap is less than US$10m (US$8.70m market cap). Minor Risk Shareholders have been diluted in the past year (7.9% increase in shares outstanding). お知らせ • Aug 30
Golden Sun Health Technology Group Limited, Annual General Meeting, Sep 26, 2024 Golden Sun Health Technology Group Limited, Annual General Meeting, Sep 26, 2024, at 10:00 China Standard Time. Location: room 503,building c2, no. 1599 xinjinqiao road, pudong new area, shanghai, China Reported Earnings • Aug 06
First half 2024 earnings released: US$0.89 loss per share (vs US$1.98 loss in 1H 2023) First half 2024 results: US$0.89 loss per share (improved from US$1.98 loss in 1H 2023). Revenue: US$3.71m (up 5.1% from 1H 2023). Net loss: US$1.76m (loss narrowed 52% from 1H 2023). New Risk • Jul 23
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: US$9.79m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (28% average weekly change). Earnings have declined by 93% per year over the past 5 years. Market cap is less than US$10m (US$9.79m market cap). Minor Risk Shareholders have been diluted in the past year (4.0% increase in shares outstanding). お知らせ • May 09
Golden Sun Health Technology Group Limited Regains Compliance with Nasdaq Continued Listing Requirement Golden Sun Health Technology Group Limited, formerly known as Golden Sun Education Group Limited (the ‘Company’ or ‘Golden Sun’) announced that the Company received a written notification (the ‘Notification Letter’) from the Nasdaq Stock Market LLC (‘Nasdaq’) on May 3, 2024, informing the Company that it has regained compliance with the Nasdaq's minimum bid price requirement. According to the Notification Letter, as of May 2, 2024, Golden Sun has maintained a closing bid price of $1.00 per share for ten consecutive trading sessions following a 1 for 10 reverse stock-split on April 19, 2024. Board Change • May 01
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Zhenghua Yu was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. お知らせ • Mar 26
Golden Sun Health Technology Group Limited Announces Receipt of Nasdaq Delisting Determination and Plan to Appeal Golden Sun Health Technology Group Limited, formerly known as Golden Sun Education Group Limited (the "Company" or "Golden Sun") announced the Company received a staff determination letter (the "Letter"), on March 21, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, due to the Company's failure to regain compliance with a minimum bid price of $1.00 per share requirement for continued listing on The Nasdaq Capital Market, as set in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Requirement"), the Staff has determined (the "Determination") that Company's securities will be scheduled for delisting from Nasdaq unless the Company requests an appeal of this determination to a Hearings Panel (the "Panel"). On September 22, 2023, the Company received a letter from Nasdaq (the "Notice"), notifying the Company that based upon the closing bid price of its Class A ordinary shares for the last 30 consecutive business days preceding the Notice, the Company was not in compliance with the Minimum Bid Requirement. In accordance with Listing Rule 5810(c)(3)(A), the Notice provided the Company a period of 180 calendar days from the date of the Notice, or until March 20, 2024, to regain compliance with the Minimum Bid Requirement. According to the Letter, the Company had not regained compliance with the Minimum Bid Requirement as of March 20, 2024 and is not eligible for a second 180-day period. Specifically, the Company does not comply with the initial listing requirement of $5,000,000 minimum stockholders' equity for The Nasdaq Capital Market, as contemplated for a second 180-day period. Unless the Company requests an appeal of the Determination by March 28, 2024, the Company's Class A ordinary shares will be suspended at the opening of business on April 2, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Company's Class A ordinary shares from listing and registration on Nasdaq. The Company plans to appeal the Determination to the Panel in due course. A hearing request will stay the suspension of the Company's securities and the filing of Form 25-NSE pending the Panel's decision. The Company is considering all options available to it, including a reverse stock split, and will provide its shareholders with material updates when they are available. お知らせ • Feb 09
Golden Sun Health Technology Group Limited Announces Resignation of Wenlong Xia from the Board of Directors Mr. Wenlong Xia, an independent director of Golden Sun Health Technology Group Ltd. (the “Company”), notified the Company of his resignation from the board of directors of the Company (“Board”) on January 8, 2024, effective immediately. The Board is the process of appointing another independent director to fill the vacancy created by his departure. お知らせ • Feb 01
Golden Sun Education Group Limited announced delayed 20-F filing On 01/31/2024, Golden Sun Education Group Limited announced that they will be unable to file their next 20-F by the deadline required by the SEC. Recent Insider Transactions Derivative • Dec 07
Chief Financial Officer notifies of intention to sell stock Yunan Huang intends to sell 151k shares in the next 90 days after lodging an Intent To Sell Form on the 4th of December. If the sale is conducted around the recent share price of US$0.49, it would amount to US$73k. As of today, Yunan currently holds no shares directly (This sale likely refers to shares that have not yet been received). There have been no trades via on-market transactions or options from company insiders in the last 12 months. New Risk • Oct 29
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Earnings have declined by 106% per year over the past 5 years. Market cap is less than US$10m (US$8.95m market cap). Minor Risk Shareholders have been diluted in the past year (4.0% increase in shares outstanding). New Risk • Oct 20
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: US$9.96m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 106% per year over the past 5 years. Market cap is less than US$10m (US$9.96m market cap). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Shareholders have been diluted in the past year (4.0% increase in shares outstanding). Reported Earnings • Oct 18
First half 2023 earnings released: US$0.20 loss per share (vs US$0.026 profit in 1H 2022) First half 2023 results: US$0.20 loss per share (down from US$0.026 profit in 1H 2022). Revenue: US$3.53m (down 51% from 1H 2022). Net loss: US$3.67m (down US$4.01m from profit in 1H 2022). Board Change • Oct 12
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Yidong Hao was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. お知らせ • Sep 27
Golden Sun Education Group Limited Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency Golden Sun Education Group Limited announced that the Company received written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on September 22, 2023, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on Nasdaq. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on the closing bid price of the Company's Class A ordinary shares for the 30 consecutive business days from August 10, 2023 to September 21, 2023, the Company no longer meets the minimum bid price requirement. The Notification Letter does not impact the Company's listing on the Nasdaq Capital Market at this time. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided 180 calendar days, or until March 20, 2024, to regain compliance with Nasdaq Listing Rule 5550(a)(2). To regain compliance, the Company's Class A ordinary shares must have a closing bid price of at least $1.00 for a minimum of 10 consecutive business days. In the event the Company does not regain compliance by March 20, 2024, the Company may be eligible for additional time to regain compliance or may face delisting. The Company's business operations are not affected by the receipt of the Notification Letter. The Company intends to monitor the closing bid price of its Class A ordinary shares and may, if appropriate, consider implementing available options, including, but not limited to, a reverse share split of its outstanding Class A ordinary shares, to regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules. お知らせ • Aug 26
Golden Sun Education Group Limited, Annual General Meeting, Sep 26, 2023 Golden Sun Education Group Limited, Annual General Meeting, Sep 26, 2023, at 10:00 Eastern Standard Time. Location: 8th Floor, Administration Building 390 East Tiyuhui road, Hongkou District, Shanghai, China Shanghai China Agenda: To re-elect Mr. Xueyuan Weng as a director of the Company to hold office until the next annual general meeting; To re-elect Ms. Peilin Ji as a director of the Company to hold office until the next annual general meeting; To re-elect Mr. Liming Xu as a director of the Company to hold office until the next annual general meeting;to re-elect Mr. Robert Travers as a director of the Company to hold office until the next annual general meeting; To change the Company’s name to “Golden Sun Health Technology Group Limited” and the Chinese translation of the Company’s name to “?????????????”. New Risk • Aug 20
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 28% over the past year. Minor Risks Latest financial reports are more than 6 months old (reported September 2022 fiscal period end). Share price has been volatile over the past 3 months (14% average weekly change). Market cap is less than US$100m (US$15.5m market cap). お知らせ • Jul 27
Golden Sun Education Group Limited Announces Changes to Its Board Golden Sun Education Group Limited announced that Mr. Jin’an Li, an independent director of the Company, notified the Company of his resignation from the board of directors of the Company (Board) on July 20, 2023, effective immediately. On July 20, 2023, the Board appointed Mr. Yidong Hao as an independent director, and a member of each of the Audit Committee, Compensation Committee, and Corporate Governance and Nominating Committee, as well as the chairperson of the Corporate Governance and Nominating Committee, to fill the vacancy created by the departure of Mr. Jin’an Li. Mr. Hao has served as the Financial Director of Haomu (Shanghai) Energy Conservation Technology Co., Ltd, since June 2017, and served as the Financial Director of Shanghai Huayuan Magnetic Industry Co. Ltd. from Feb. 2015 to June 2017. Mr. Hao graduated from Nankai University in China in 1997, majoring in accounting, and received his master’s degree in Software Engineering from Fudan University in China in 2015. Recent Insider Transactions Derivative • Jul 10
Chief Financial Officer notifies of intention to sell stock Yunan Huang intends to sell 151k shares in the next 90 days after lodging an Intent To Sell Form on the 10th of July. If the sale is conducted around the recent share price of US$1.50, it would amount to US$226k. As of today, Yunan currently holds no shares directly (This sale likely refers to shares that have not yet been received). There have been no trades via on-market transactions or options from company insiders in the last 12 months. お知らせ • Feb 01
Golden Sun Education Group Limited announced delayed 20-F filing On 01/31/2023, Golden Sun Education Group Limited announced that they will be unable to file their next 20-F by the deadline required by the SEC. Valuation Update With 7 Day Price Move • Jan 23
Investor sentiment deteriorates as stock falls 27% After last week's 27% share price decline to US$1.61, the stock trades at a trailing P/E ratio of 46x. Average trailing P/E is 20x in the Consumer Services industry in the US. Valuation Update With 7 Day Price Move • Jan 05
Investor sentiment improved over the past week After last week's 22% share price gain to US$1.26, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 20x in the Consumer Services industry in the US. Valuation Update With 7 Day Price Move • Dec 16
Investor sentiment deteriorated over the past week After last week's 16% share price decline to US$1.12, the stock trades at a trailing P/E ratio of 32x. Average trailing P/E is 19x in the Consumer Services industry in the US. Valuation Update With 7 Day Price Move • Nov 22
Investor sentiment deteriorated over the past week After last week's 65% share price decline to US$2.11, the stock trades at a trailing P/E ratio of 60.3x. Average trailing P/E is 17x in the Consumer Services industry in the US. Reported Earnings • Aug 17
First half 2022 earnings released: EPS: US$0 (vs US$0.097 in 1H 2021) First half 2022 results: EPS: US$0 (down from US$0.097 in 1H 2021). Revenue: US$7.21m (down 36% from 1H 2021). Net income: US$332.1k (down 77% from 1H 2021). Profit margin: 4.6% (down from 13% in 1H 2021). The decrease in margin was driven by lower revenue. お知らせ • Jun 24
Golden Sun Education Group Limited (NasdaqCM:GSUN) completed the acquisition of Shanghai Yangpu District Jicai Tutorial School. Golden Sun Education Group Limited (NasdaqCM:GSUN) acquired Shanghai Yangpu District Jicai Tutorial School on December 31, 2016.
Golden Sun Education Group Limited (NasdaqCM:GSUN) completed the acquisition of Shanghai Yangpu District Jicai Tutorial School on December 31, 2016. お知らせ • Jun 23
Golden Sun Education Group Limited has completed an IPO in the amount of $17.6 million. Golden Sun Education Group Limited has completed an IPO in the amount of $17.6 million.
Security Name: Class A Ordinary Shares
Security Type: Common Stock
Securities Offered: 4,400,000
Price\Range: $4
Discount Per Security: $0.375 Board Change • Jun 22
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Director Peilin Ji was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.